ATE73347T1 - Antivirales immunotherapeutisches mittel und dessen herstellung. - Google Patents

Antivirales immunotherapeutisches mittel und dessen herstellung.

Info

Publication number
ATE73347T1
ATE73347T1 AT86906571T AT86906571T ATE73347T1 AT E73347 T1 ATE73347 T1 AT E73347T1 AT 86906571 T AT86906571 T AT 86906571T AT 86906571 T AT86906571 T AT 86906571T AT E73347 T1 ATE73347 T1 AT E73347T1
Authority
AT
Austria
Prior art keywords
immunotherapeutic agent
production
man
present
antiviral immunotherapeutic
Prior art date
Application number
AT86906571T
Other languages
English (en)
Inventor
William L Ragland
Original Assignee
Vetrepharm Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetrepharm Research Inc filed Critical Vetrepharm Research Inc
Application granted granted Critical
Publication of ATE73347T1 publication Critical patent/ATE73347T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86906571T 1985-10-08 1986-10-08 Antivirales immunotherapeutisches mittel und dessen herstellung. ATE73347T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/785,070 US4744984A (en) 1985-10-08 1985-10-08 Antiviral immunotherapeutic agent and preparation thereof
PCT/US1986/002118 WO1987002249A1 (en) 1985-10-08 1986-10-08 Antiviral immunotherapeutic agent and preparation thereof
EP86906571A EP0238657B1 (de) 1985-10-08 1986-10-08 Antivirales immunotherapeutisches mittel und dessen herstellung

Publications (1)

Publication Number Publication Date
ATE73347T1 true ATE73347T1 (de) 1992-03-15

Family

ID=25134365

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86906571T ATE73347T1 (de) 1985-10-08 1986-10-08 Antivirales immunotherapeutisches mittel und dessen herstellung.

Country Status (8)

Country Link
US (1) US4744984A (de)
EP (1) EP0238657B1 (de)
AT (1) ATE73347T1 (de)
AU (1) AU605116B2 (de)
CA (1) CA1293190C (de)
DE (1) DE3684305D1 (de)
NO (1) NO874364D0 (de)
WO (1) WO1987002249A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380484B1 (de) * 1988-05-26 1993-08-18 Nika Health Products Limited Verwendung eines Lysozymdimeren und/oder Ribonucleasedimeren zur Herstellung eines antiviralen oder antibakteriellen Arzneimittels
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CN1102855C (zh) * 1993-01-29 2003-03-12 维特里制药有限公司 免疫治疗组合物
WO1995005837A1 (en) * 1993-08-27 1995-03-02 Vetrepharm, Inc. Composition and method for stimulation of reproductive performance
AU726330B2 (en) * 1993-08-27 2000-11-02 Vetrepharm, Inc. Composition and method for stimulation of reproductive performance
RU2040932C1 (ru) * 1993-12-17 1995-08-09 Крестьянское хозяйство "Агрофирма Дижа" Препарат, влияющий на тканевой обмен и применение штамма гриба fusarium sambucinum fuckel var ossicolum (berk.et curf) bilai для его получения
DE4422859C2 (de) * 1994-06-30 2000-10-05 Laves Arzneimittel Gmbh Wäßrige Zellextrakte aus Mykobacterien
US6303295B1 (en) * 1995-07-14 2001-10-16 University Of Georgia Research Foundation, Inc. Selenoproteins, coding sequences and methods
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
CA2284932A1 (en) * 1997-04-02 1998-10-08 Nigel C. Phillips Use of bacterial cell wall extracts for treating topical disorders and wounds
PT1003525E (pt) 1997-08-05 2003-03-31 Bioniche Life Sciences Inc Composicao e metodo para a regulacao da proliferacao e da morte celular
US6890541B1 (en) 1999-07-23 2005-05-10 Bioniche Life Sciences, Inc. Method for enhancing production performance in an animal
CZ20022372A3 (cs) * 1999-12-13 2002-11-13 Bioniche Life Sciences Inc. Terapeuticky pouľitelné syntetické oligonukleotidy
US7125858B2 (en) * 1999-12-28 2006-10-24 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
WO2002053181A1 (en) 2001-01-04 2002-07-11 University Of Saskatchewan Enterohemorragic escherichia coli vaccine
JP4859341B2 (ja) * 2001-07-19 2012-01-25 昭 林 ヒト免疫療法
CN1296059C (zh) * 2003-04-04 2007-01-24 张素琴 草分支杆菌免疫液
EP2462948A1 (de) 2003-10-31 2012-06-13 The University Of British Columbia Bakterielle Virulenzfaktoren und Verwendungen davon
ES2231037B1 (es) * 2003-10-31 2005-12-16 Archivel Technologies, Sl Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos.
DK2162149T3 (da) 2007-06-01 2014-02-10 Jackson H M Found Military Med Vaccine til forebyggelse af brystkræfttilbagefald
ES2639577T3 (es) 2008-12-10 2017-10-27 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Vacuna para la prevención de la recurrencia del cáncer de mama
WO2011020094A1 (en) * 2009-08-14 2011-02-17 The Board Of Regents Of The University Of Texas System Use of synthetic single-stranded rna (ssrna) as a therapeutic agent to activate nod2-dependent immune response against viral infection
HUE052413T2 (hu) 2010-10-13 2021-04-28 Telesta Therapeutics Inc Bakteriális ribonukleinsav-sejtfalkészítmények és elõállítási és felhasználási módszereik
ITTO20120346A1 (it) 2012-04-18 2013-10-19 Turmond S P A Coltello multiplo rotante per il taglio longitudinale di nastri
EP2877205A4 (de) 2012-07-26 2016-04-06 Jackson H M Found Military Med Impfstoff mit einem multimeren fusionsprotein und immuntherapeutikum
EP2777711A1 (de) 2013-03-11 2014-09-17 Icon Genetics GmbH HER2/neu-Krebsimpfstoff
US10226520B2 (en) 2014-03-04 2019-03-12 The Board Of Regents Of The University Of Texa System Compositions and methods for enterohemorrhagic Escherichia coli (EHEC) vaccination
US9579370B2 (en) 2014-03-04 2017-02-28 The Board Of Regents Of The University Of Texas System Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination
WO2017011919A1 (en) 2015-07-22 2017-01-26 University Of Saskatchewan Mycoplasma vaccines and uses thereof
WO2021173919A1 (en) * 2020-02-28 2021-09-02 Shaw Industries Group, Inc. Barrel valve
WO2021185851A1 (en) 2020-03-17 2021-09-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Vaccine compositions for hiv prevention and treatment
MX2022013152A (es) 2020-04-20 2023-02-09 Univ Saskatchewan Composiciones y métodos para prevenir, controlar y diagnosticar infecciones por micobacterias.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
US3331741A (en) * 1964-12-03 1967-07-18 Warner Lambert Pharmaceutical Process for the preparation of a soluble bacterial extract
FR2184531B1 (de) * 1972-05-19 1975-10-17 Anvar
US4069314A (en) * 1973-02-23 1978-01-17 Christopher Adlam Glycopeptide extract
US4340586A (en) * 1977-02-18 1982-07-20 Adam Bekierkunst Pharmaceutical preparation for treating disorders of the skin
US4520019A (en) * 1982-04-29 1985-05-28 Ribi Immunochem Research, Inc. Stable composition and preparation thereof
US4504473A (en) * 1982-06-30 1985-03-12 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4503048A (en) * 1982-06-30 1985-03-05 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4505903A (en) * 1982-06-30 1985-03-19 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
AU605116B2 (en) 1991-01-10
EP0238657B1 (de) 1992-03-11
DE3684305D1 (de) 1992-04-16
EP0238657A1 (de) 1987-09-30
US4744984A (en) 1988-05-17
AU6525886A (en) 1987-05-05
EP0238657A4 (de) 1988-05-31
WO1987002249A1 (en) 1987-04-23
CA1293190C (en) 1991-12-17
NO874364D0 (no) 1987-10-20

Similar Documents

Publication Publication Date Title
ATE73347T1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
SG17493G (en) Ozone decontamination of blood and blood products
DE3684363D1 (de) Phosphonylmethoxyalkyl-adeninen zur behandlung von viruskrankheiten.
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
DE3750934D1 (de) Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten.
DE3780091D1 (de) Behandlung von pilzinfektionen.
ATE179333T1 (de) Immunotherapeutische zubereitung
GR3005768T3 (de)
AU7679787A (en) Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor
FI880961A0 (fi) Synergistisk effekt av lymfokiner och dubbelstraengade rna-sekvenser.
ATE135914T1 (de) Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung.
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
PT600396E (pt) Vacinas contra protozoarios intestinais
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DE69127713D1 (de) Behandlung von Abgasen, die Silikon- und/oder Phosphorverbindungen enthalten
HUP9900945A2 (hu) Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
ATE30114T1 (de) Mittel zur pflege oder behandlung der menschlichen haut.
NL194153B (nl) Preparaat bestemd voor de profylaxe of behandeling van protozoÙninfecties bij dieren.
FI872459A7 (fi) Farmaseuttinen valmiste bakteeri-infektioiden hoitoon.
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
FR2593703B1 (fr) Application du butyl-4-diphenyl-1,2-pyrazolidine-dione-3,5 comme agent antiviral chez l'homme ou l'animal
MX9400210A (es) Tratamiento de infecciones virales.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time